Skip to content
Menu

Actuate Therapeutics, Inc. Common stock ACTU

Full chart Compare
Set alert

Price alert · ACTU

All alert types
0.21 USD -0.03 (-12.95%)

Regular-session close

0.20 -0.01 -6.45%

Pre-market · Nov 20, 4:18 AM ET

0.1741 Day range 0.23
0.1741 52-week range 7.90
YTD
-96.51%
1 year
-96.35%

5D -0.0684 (-21.38%)

0.25000.3000WedThuFriMonTue0.2516
Market cap
12.91M
EPS (ttm)
-0.76
Shares out
19.53M
YTD return
-96.51%
1-year return
-96.35%
50-day average
8.35
Volume
2.99M
Avg volume
769.16K
Open
0.2148
Previous close
0.2456
Day's range
0.1741 – 0.23
52-week range
0.1741 – 7.90

Key statistics

200-day average
8.07
Enterprise value
268.98M
Total cash
351.71K
Total debt
6.90M

Fundamental scorecard

3 of 25 checks passed on ACTU’s reported financials

ValueGrowthProfitabilityHealthDividend

3of 25 checks passed

  • Value 0 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
ACTU Revenue — quarterly 0
ACTU Net income — quarterly -3.42M
ACTU EPS — quarterly -0.14

About Actuate Therapeutics, Inc. Common stock

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on ACTU — it syncs with the Stock Master app.

Institution ownership

ACTU institution ownership
Holder% heldSharesValueReported
AWM Investment Company, Inc.0.71%139,5111.05MSep 29, 2024
Long Corridor Asset Management Ltd0.64%125,000941.25KSep 29, 2024
Royal Bank of Canada0.18%35,300265.81KSep 29, 2024
Geode Capital Management, LLC0.14%27,893210.03KSep 29, 2024
Northwestern University0.14%27,778209.17KSep 29, 2024
KG&L Capital Management,LLC0.06%12,00090.36KSep 29, 2024

Fund ownership

ACTU fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.08%16,158121.67KOct 30, 2024
Fidelity Total Market Index Fund0.03%5,49241.35KOct 30, 2024
Fidelity Series Total Market Index Fund0.02%3,85229.00KOct 30, 2024